Showing results (51-60 of 59) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 59 results.
International Journal of Biological Macromolecules|May 14, 2025
In vitro evaluation of the therapeutic efficacy of Moringa oleifera and oxaliplatin in 3D printed polycaprolactone/gelatin implantable patches: A potential strategy for overcoming drug resistance in colorectal cancer treatmentHasan Ege, Gozde Enguven, Asuman Celebi, et al.
Seizure|March 21, 2006
Lack of association between IL-1beta/alpha gene polymorphisms and temporal lobe epilepsy with hippocampal sclerosisCigdem Ozkara, Mustafa Uzan, Taner Tanriverdi, et al.
Biochemical Genetics|September 10, 2025
Exploring Differentially Expressed Genes and Understanding the Underlying Mechanisms in GlioblastomaDidem Seven, Arif Ekici, Steffen Uebe, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|December 29, 2011
JAK2 (V617F) mutation is not associated with thrombosis in Behcet syndromeM Cem Ar, Gülen Hatemi, Seda Ekizoğlu, et al.
Pituitary|January 2, 2004
G protein mutations in pituitary tumors: a study on Turkish patientsBeki Kan, Christopher Esapa, Tammam Sipahi, et al.
Rheumatology International|August 23, 2017
Familial Mediterranean fever in childhood: a single-center experienceKenan Barut, Sezgin Sahin, Amra Adrovic, et al.
Turkish Journal of Haematology : Official Journal of Turkish Society of Haematology|April 19, 2014
The Association Between JAK2V617F Mutation and Bone Marrow Fibrosis at Diagnosis in Patients with Philadelphia-Negative Chronic Myeloproliferative NeoplasmsM Cem Arı, Deram Büyüktaş, A Emre Eşkazan, et al.
Turkish Journal of Haematology : Official Journal of Turkish Society of Haematology|June 7, 2016
Looking for Our Ten Years Results for Coronary Heart Disease and Ischemic Stroke Group for the Standpoint of HaemostasisTurgut Ulutin, Hüseyin Sönmez, Nergis Domaniç, et al.
Journal of Clinical Pathology|January 27, 2016
Imatinib reduces bone marrow fibrosis and overwhelms the adverse prognostic impact of reticulin formation in patients with chronic myeloid leukaemiaEda Tanrikulu Simsek, Ahmet Emre Eskazan, Mahir Cengiz, et al.
Pageof 6